Skip to main content
See every side of every news story
Published loading...Updated

Medios Acquires 74% Majority Stake in Caelo

Summary by bionity.com
Medios AG has signed an agreement to acquire 74% of the shares in Caesar & Loretz GmbH (Caelo), subject to antitrust approval. Caelo, headquartered in Hilden, is a leading supplier of pharmaceutical active ingredients (APIs), excipients, and raw materials...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Medios AG has signed an agreement to acquire 74% of the shares in Caesar & Loretz GmbH (Caelo), subject to antitrust approval. Caelo, headquartered in Hilden, is a leading supplier of pharmaceutical active ingredients (APIs), excipients, and raw materials...

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

bionity.com broke the news on Thursday, August 13, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal